Jump to content

Tretoquinol

From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by Maxim Masiutin (talk | contribs) at 01:02, 1 March 2024 (Altered template type. Add: pages, issue, volume, journal, pmid, date, authors 1-10. | Use this tool. Report bugs. | #UCB_Gadget). The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Tretoquinol
Names
Preferred IUPAC name
(1S)-1-[(3,4,5-Trimethoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline-6,7-diol
Identifiers
3D model (JSmol)
ChEMBL
ChemSpider
MeSH Tretoquinol
UNII
  • InChI=1S/C19H23NO5/c1-23-17-7-11(8-18(24-2)19(17)25-3)6-14-13-10-16(22)15(21)9-12(13)4-5-20-14/h7-10,14,20-22H,4-6H2,1-3H3/t14-/m0/s1 checkY
    Key: RGVPOXRFEPSFGH-AWEZNQCLSA-N checkY
  • InChI=1/C19H23NO5/c1-23-17-7-11(8-18(24-2)19(17)25-3)6-14-13-10-16(22)15(21)9-12(13)4-5-20-14/h7-10,14,20-22H,4-6H2,1-3H3/t14-/m0/s1
    Key: RGVPOXRFEPSFGH-AWEZNQCLBM
  • O(c1cc(cc(OC)c1OC)C[C@H]3c2c(cc(O)c(O)c2)CCN3)C
Properties
C19H23NO5
Molar mass 345.39 g/mol
Pharmacology
R03AC09 (WHO)
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)

Tretoquinol is a beta-adrenergic agonist.[1][2]

References

[edit]
  1. ^ Yamato, E.; Hirakura, M.; Sugasawa, S. (1966). "Synthesis of 6,7-dihydrox-1,2,3,4-tetrahydroisoquinoline derivatives". Tetrahedron. 22: 129–134. doi:10.1016/S0040-4020(01)82177-3.
  2. ^ Konkar, A. A.; Vansal, S. S.; Shams, G.; Fraundorfer, P. F.; Zheng, W. P.; Nikulin, V. I.; De Los Angeles, J.; Fertel, R. H.; Miller, D. D.; Feller, D. R. (1999-11-01). "β-Adrenoceptor Subtype Activities of Trimetoquinol Derivatives: Biochemical Studies on Human β-Adrenoceptors Expressed in Chinese Hamster Ovary Cells". The Journal of Pharmacology and Experimental Therapeutics. 291 (2). Jpet.aspetjournals.org: 875–883. PMID 10525112. Retrieved 2012-08-20.